GUYER WILLIAM (Chief Development Officer) received a stock award from CORCEPT THERAPEUTICS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 9/4/2026ACC: 0001193125-26-382475
Officer· Chief Development Officer
Since Aug 2021
+328.00
Net shares
Net buyer
$18.6K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
328.00 acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+164.00
Price / share
$113.38
Trade value
$18.59K
% of position
4.1%
9/1/2026
3.98K→4.15K
Common Stock
Direct
Shares
+164.00
Price / share
—
Trade value
—
% of position
4.0%
9/1/2026
4.15K→4.31K
Total
Net shares
+328.00
Net value
$18.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2026 | A · Award | +164.00 | $113.38 | $18.59K | 4.1% | 3.98K | 4.15K |
| Common Stock Direct | 9/1/2026 | A · Award | +164.00 | — | — | 4.0% | 4.15K | 4.31K |
| Total | +328.00 | $18.59K | ||||||
Derivative Transactions0
No derivative transactions reported